STAGNO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 480
EU - Europa 310
AF - Africa 104
AS - Asia 84
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 981
Nazione #
US - Stati Uniti d'America 464
IT - Italia 124
IE - Irlanda 90
CI - Costa d'Avorio 75
CN - Cina 46
SN - Senegal 27
DE - Germania 23
UA - Ucraina 22
VN - Vietnam 18
CA - Canada 15
RU - Federazione Russa 15
SE - Svezia 8
GB - Regno Unito 6
UZ - Uzbekistan 5
FR - Francia 4
AT - Austria 3
BE - Belgio 3
IN - India 3
LB - Libano 3
NL - Olanda 3
SG - Singapore 3
BR - Brasile 2
HK - Hong Kong 2
NG - Nigeria 2
PL - Polonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 981
Città #
Chandler 169
Dublin 90
Abidjan 75
Catania 37
Ashburn 27
Dakar 27
Cambridge 23
Lawrence 23
Andover 22
Houston 22
Jacksonville 18
Dong Ket 14
Des Moines 13
Grafing 13
Nanjing 12
Wilmington 12
Ottawa 7
Hanover 6
Los Angeles 6
Saint Petersburg 6
Beijing 5
Boardman 5
Falls Church 5
Giardini-Naxos 5
Jiaxing 5
Toronto 5
Hanoi 4
Hebei 4
Nanchang 4
Palermo 4
Santa Venerina 4
Bremen 3
Brooklyn 3
Brussels 3
Seattle 3
Abuja 2
Assago 2
Fremont 2
Jinan 2
Messina 2
Milan 2
Montreal 2
Pune 2
Redwood City 2
Rome 2
San Mateo 2
Sant'Agata di Militello 2
Shenyang 2
Singapore 2
Siracusa 2
São Paulo 2
Washington 2
Zhengzhou 2
Ancona 1
Augusta 1
Bagnolo Cremasco 1
Bari 1
Bergamo 1
Bratislava 1
Casamassima 1
Changsha 1
Chicago 1
Dubai 1
Edinburgh 1
Frankfurt am Main 1
Groningen 1
Guangzhou 1
Hyderabad 1
Kocaeli 1
Luxembourg 1
Madrid 1
Manchester 1
Mascali 1
Miami 1
Moscow 1
Nanaimo 1
New York 1
Ningbo 1
Oslo 1
Piraino 1
Polska 1
Prague 1
Providence 1
Ramacca 1
Redmond 1
Riyadh 1
Rotterdam 1
San Giovanni la Punta 1
Santa Clara 1
Spezzano Della Sila 1
Tepatitlán de Morelos 1
Verona 1
Villamagna 1
Woodbridge 1
Totale 761
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 83
In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside 62
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 57
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 51
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 51
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 51
Uncommon long-term survival in a patient with chronic myeloid leukemia 48
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 46
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 45
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 45
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 44
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 44
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 44
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 42
Evaluation of taxol cytotoxicity on B-CLL cells in vitro 39
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 38
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 37
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 35
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 33
Differences among young adults, adults and elderly chronic myeloid leukemia patients 31
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 31
Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients 28
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 28
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 18
A case of high-risk AML in a patient with advanced systemic mastocytosis 14
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions 6
Totale 1.051
Categoria #
all - tutte 4.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 2 5
2019/2020135 29 5 9 3 18 14 4 14 5 3 9 22
2020/2021112 8 4 5 11 29 7 8 1 17 1 5 16
2021/2022164 4 24 3 3 34 5 27 4 9 1 9 41
2022/2023432 28 48 16 50 31 64 1 80 85 5 18 6
2023/2024178 13 40 8 12 8 66 1 15 5 10 0 0
Totale 1.051